Suchitra Ella, joint managing director, Bharat Biotech | Photo: Twitter
Bharat Biotech’s Joint Managing Director Suchitra Ella’s tweet saying 50 of their employees tested positive for Covid received bouquets and brickbats from netizens with some saying Covaxin was saving lives while a few questioned as to why the staff were not vaccinated.
Referring to comments by some political bosses over Covid-19 vaccine Covaxin supply issues, Ella on Wednesday tweeted: “Quite disheartening to the teams to hear some states complaining about our intentions. 50 of our employees are off work due to covid, yet we continue to work under pandemic lockdowns 24x7 for U”.
Reacting to her tweet, one user wrote: “How come your 50 employees down with Covid? Were they not vaccinated? Also, why not hire more people on temporary basis?” Ella’s tweet got 9,373 likes and was retweeted by 2,564 people (at 10:30 am on May 13).
“Hi just wanted to say Thank you. Both my grandparents are over 75 & took their first jab 5 weeks back, both tested Covid-positive 2 weeks back. Low fever were their only symptoms, tested negative today, on the road to recovery with no major issues,” tweeted another netizen. “Thank you Bharat Biotech
for your hard work and commitment on delivering vaccines every corner of India,” another user said.
Another user said, “If you say that your employees are sick of covid, it speaks volumes about efficacy of your vaccine.”
Ella said as many as 18 states received Covaxin though in smaller shipments.
The firm is supplying Covaxin to 18 states, including AP, Haryana, Odisha, Assam, J&K, Tamil Nadu, Bihar, Jharkhand as well as Delhi.
The other states are Chhattisgarh, Karnataka, Telangana, Tripura, Madhya Pradesh, Uttar Pradesh, Gujarat, Maharashtra and West Bengal.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.